Borosil Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 28, 2025, 10:32 am

Competitors of Borosil Ltd

All Competitor Stocks of Borosil Ltd

Quarterly Result

Last Updated: May 31, 2025, 6:39 am

Below is a detailed analysis of the quarterly data for Borosil Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 270.00 Cr.. The value appears to be declining and may need further review. It has decreased from 338.00 Cr. (Dec 2024) to 270.00 Cr., marking a decrease of 68.00 Cr..
• For Expenses, as of Mar 2025, the value is 233.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 284.00 Cr. (Dec 2024) to 233.00 Cr., marking a decrease of 51.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 37.00 Cr.. The value appears to be declining and may need further review. It has decreased from 54.00 Cr. (Dec 2024) to 37.00 Cr., marking a decrease of 17.00 Cr..
• For OPM %, as of Mar 2025, the value is 14.00%. The value appears to be declining and may need further review. It has decreased from 16.00% (Dec 2024) to 14.00%, marking a decrease of 2.00%.
• For Other Income, as of Mar 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 16.00 Cr. (Dec 2024) to 2.00 Cr., marking a decrease of 14.00 Cr..
• For Interest, as of Mar 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 2.00 Cr..
• For Depreciation, as of Mar 2025, the value is 20.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 21.00 Cr. (Dec 2024) to 20.00 Cr., marking a decrease of 1.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 17.00 Cr.. The value appears to be declining and may need further review. It has decreased from 48.00 Cr. (Dec 2024) to 17.00 Cr., marking a decrease of 31.00 Cr..
• For Tax %, as of Mar 2025, the value is 34.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Dec 2024) to 34.00%, marking an increase of 9.00%.
• For Net Profit, as of Mar 2025, the value is 11.00 Cr.. The value appears to be declining and may need further review. It has decreased from 35.00 Cr. (Dec 2024) to 11.00 Cr., marking a decrease of 24.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 0.93. The value appears to be declining and may need further review. It has decreased from 2.97 (Dec 2024) to 0.93, marking a decrease of 2.04.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 3:44 am

Growth

Last Updated: September 5, 2025, 2:46 pm

Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Borosil Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 6.28. This value is within the healthy range. It has increased from 5.75 (Mar 24) to 6.28, marking an increase of 0.53.
• For Diluted EPS (Rs.), as of Mar 25, the value is 6.28. This value is within the healthy range. It has increased from 5.75 (Mar 24) to 6.28, marking an increase of 0.53.
• For Cash EPS (Rs.), as of Mar 25, the value is 12.99. This value is within the healthy range. It has increased from 10.45 (Mar 24) to 12.99, marking an increase of 2.54.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 67.57. It has increased from 50.62 (Mar 24) to 67.57, marking an increase of 16.95.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 67.57. It has increased from 50.62 (Mar 24) to 67.57, marking an increase of 16.95.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 92.68. It has increased from 82.23 (Mar 24) to 92.68, marking an increase of 10.45.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 16.49. This value is within the healthy range. It has increased from 13.14 (Mar 24) to 16.49, marking an increase of 3.35.
• For PBIT / Share (Rs.), as of Mar 25, the value is 9.71. This value is within the healthy range. It has increased from 8.43 (Mar 24) to 9.71, marking an increase of 1.28.
• For PBT / Share (Rs.), as of Mar 25, the value is 8.64. This value is within the healthy range. It has increased from 7.67 (Mar 24) to 8.64, marking an increase of 0.97.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 6.21. This value is within the healthy range. It has increased from 5.75 (Mar 24) to 6.21, marking an increase of 0.46.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 6.21. This value is within the healthy range. It has increased from 5.75 (Mar 24) to 6.21, marking an increase of 0.46.
• For PBDIT Margin (%), as of Mar 25, the value is 17.78. This value is within the healthy range. It has increased from 15.97 (Mar 24) to 17.78, marking an increase of 1.81.
• For PBIT Margin (%), as of Mar 25, the value is 10.47. This value is within the healthy range. It has increased from 10.25 (Mar 24) to 10.47, marking an increase of 0.22.
• For PBT Margin (%), as of Mar 25, the value is 9.32. This value is below the healthy minimum of 10. There is no change compared to the previous period (Mar 24) which recorded 9.32.
• For Net Profit Margin (%), as of Mar 25, the value is 6.70. This value is within the healthy range. It has decreased from 6.99 (Mar 24) to 6.70, marking a decrease of 0.29.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.70. This value is below the healthy minimum of 8. It has decreased from 6.99 (Mar 24) to 6.70, marking a decrease of 0.29.
• For Return on Networth / Equity (%), as of Mar 25, the value is 9.19. This value is below the healthy minimum of 15. It has decreased from 11.35 (Mar 24) to 9.19, marking a decrease of 2.16.
• For Return on Capital Employeed (%), as of Mar 25, the value is 13.18. This value is within the healthy range. It has decreased from 13.90 (Mar 24) to 13.18, marking a decrease of 0.72.
• For Return On Assets (%), as of Mar 25, the value is 6.56. This value is within the healthy range. It has increased from 6.10 (Mar 24) to 6.56, marking an increase of 0.46.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. It has decreased from 0.16 (Mar 24) to 0.05, marking a decrease of 0.11.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.09. This value is within the healthy range. It has decreased from 0.26 (Mar 24) to 0.09, marking a decrease of 0.17.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.00. It has increased from 0.82 (Mar 24) to 1.00, marking an increase of 0.18.
• For Current Ratio (X), as of Mar 25, the value is 1.96. This value is within the healthy range. It has increased from 1.18 (Mar 24) to 1.96, marking an increase of 0.78.
• For Quick Ratio (X), as of Mar 25, the value is 0.63. This value is below the healthy minimum of 1. It has increased from 0.52 (Mar 24) to 0.63, marking an increase of 0.11.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.78. This value is below the healthy minimum of 4. It has increased from 0.24 (Mar 24) to 3.78, marking an increase of 3.54.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 15.42. This value is within the healthy range. It has decreased from 17.17 (Mar 24) to 15.42, marking a decrease of 1.75.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 6.81. This value is within the healthy range. It has decreased from 8.51 (Mar 24) to 6.81, marking a decrease of 1.70.
• For Enterprise Value (Cr.), as of Mar 25, the value is 4,071.19. It has decreased from 4,238.73 (Mar 24) to 4,071.19, marking a decrease of 167.54.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.68. This value exceeds the healthy maximum of 3. It has decreased from 4.50 (Mar 24) to 3.68, marking a decrease of 0.82.
• For EV / EBITDA (X), as of Mar 25, the value is 20.66. This value exceeds the healthy maximum of 15. It has decreased from 28.16 (Mar 24) to 20.66, marking a decrease of 7.50.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.61. This value exceeds the healthy maximum of 3. It has decreased from 4.34 (Mar 24) to 3.61, marking a decrease of 0.73.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Price / BV (X), as of Mar 25, the value is 4.95. This value exceeds the healthy maximum of 3. It has decreased from 7.05 (Mar 24) to 4.95, marking a decrease of 2.10.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.61. This value exceeds the healthy maximum of 3. It has decreased from 4.34 (Mar 24) to 3.61, marking a decrease of 0.73.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness